These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6229439

  • 21. Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait.
    Mathews CE, Leiter EH.
    Diabetes; 1999 Nov; 48(11):2189-96. PubMed ID: 10535453
    [Abstract] [Full Text] [Related]

  • 22. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse.
    Grankvist K, Marklund SL, Täljedal IB.
    Biochem J; 1981 Nov 01; 199(2):393-8. PubMed ID: 7041886
    [Abstract] [Full Text] [Related]

  • 23. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W, Schott-Ohly P, Schulte im Walde S, Gleichmann H.
    Exp Clin Endocrinol Diabetes; 2004 Jan 01; 112(1):29-37. PubMed ID: 14758569
    [Abstract] [Full Text] [Related]

  • 24. Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin-producing cells.
    Elsner M, Gurgul-Convey E, Lenzen S.
    Free Radic Biol Med; 2006 Sep 01; 41(5):825-34. PubMed ID: 16895803
    [Abstract] [Full Text] [Related]

  • 25. [New hypotheses for the mechanisms of streptozotocin and alloxan inducing diabetes mellitus].
    Kawada J.
    Yakugaku Zasshi; 1992 Nov 01; 112(11):773-91. PubMed ID: 1484345
    [Abstract] [Full Text] [Related]

  • 26. Protection against streptozotocin-induced diabetes by superoxide dismutase.
    Robbins MJ, Sharp RA, Slonim AE, Burr IM.
    Diabetologia; 1980 Jan 01; 18(1):55-8. PubMed ID: 6444904
    [Abstract] [Full Text] [Related]

  • 27. The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects.
    Thaete LG, Crouch RK, Buse MG, Spicer SS.
    Diabetologia; 1985 Sep 01; 28(9):677-82. PubMed ID: 3905479
    [Abstract] [Full Text] [Related]

  • 28. Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.
    Gaulton GN, Schwartz JL, Eardley DD.
    Diabetologia; 1985 Oct 01; 28(10):769-75. PubMed ID: 2933286
    [Abstract] [Full Text] [Related]

  • 29. Alloxan acts as a prooxidant only under reducing conditions: influence of melatonin.
    Brömme HJ, Ebelt H, Peschke D, Peschke E.
    Cell Mol Life Sci; 1999 Mar 01; 55(3):487-93. PubMed ID: 10228562
    [Abstract] [Full Text] [Related]

  • 30. DNA repair synthesis in the pancreatic islets of streptozotocin-treated mice.
    Sandler S, Swenne I.
    Diabetes Res; 1985 Sep 01; 2(5):255-8. PubMed ID: 2933209
    [Abstract] [Full Text] [Related]

  • 31. The inhibition of islet superoxide dismutase by diabetogenic drugs.
    Crouch RK, Gandy SE, Kimsey G, Galbraith RA, Galbraith GM, Buse MG.
    Diabetes; 1981 Mar 01; 30(3):235-41. PubMed ID: 6451462
    [No Abstract] [Full Text] [Related]

  • 32. Specificity of inhibition of calcium- and calmodulin-dependent protein kinase by alloxan.
    Norling LL, Colca JR, Brooks CL, Kloepper RF, McDaniel ML, Landt M.
    Biochim Biophys Acta; 1984 Sep 28; 801(2):197-205. PubMed ID: 6236851
    [Abstract] [Full Text] [Related]

  • 33. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.
    Uchigata Y, Yamamoto H, Nagai H, Okamoto H.
    Diabetes; 1983 Apr 28; 32(4):316-8. PubMed ID: 6299867
    [Abstract] [Full Text] [Related]

  • 34. Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin.
    Friesen NT, Büchau AS, Schott-Ohly P, Lgssiar A, Gleichmann H.
    Diabetologia; 2004 Apr 28; 47(4):676-85. PubMed ID: 15298345
    [Abstract] [Full Text] [Related]

  • 35. Oxygen radical production during ischemia-reperfusion in the isolated perfused rat liver as monitored by luminol enhanced chemiluminescence.
    Okuda M, Ikai I, Chance B, Kumar C.
    Biochem Biophys Res Commun; 1991 Jan 15; 174(1):217-21. PubMed ID: 1989601
    [Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage.
    Zhang HN, He JH, Yuan L, Lin ZB.
    Life Sci; 2003 Sep 19; 73(18):2307-19. PubMed ID: 12941433
    [Abstract] [Full Text] [Related]

  • 37. Islet cell membrane alteration by diabetogenic drugs.
    Orci L, Amherdt M, Malaisse-Lagae F, Ravazzola M, Malaisse WJ, Perrelet A, Renold AE.
    Lab Invest; 1976 May 19; 34(5):451-4. PubMed ID: 131879
    [Abstract] [Full Text] [Related]

  • 38. Detection of activated O2 species in vitro and in rat lungs by chemiluminescence.
    Archer SL, Nelson DP, Weir EK.
    J Appl Physiol (1985); 1989 Nov 19; 67(5):1912-21. PubMed ID: 2532194
    [Abstract] [Full Text] [Related]

  • 39. Enhanced alloxan-induced beta-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase.
    Sentman ML, Jonsson LM, Marklund SL.
    Free Radic Biol Med; 1999 Oct 19; 27(7-8):790-6. PubMed ID: 10515583
    [Abstract] [Full Text] [Related]

  • 40. Intermediate cells of the pancreas. 3. Selective autophagy and destruction of beta-granules in intermediate cells of the rat pancreas induced by alloxan and streptozotocin.
    Melmed RN, Benitez CJ, Holt SJ.
    J Cell Sci; 1973 Jul 19; 13(1):297-315. PubMed ID: 4269735
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.